The best indicator for Raymond James Financial (RJF)
We backtested 20 indicators across daily, weekly and hourly charts on real Raymond James Financial (RJF) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
WaveTrend (8/6/4)
On the weekly chart, this is the strongest risk-adjusted edge we found for Raymond James Financial (RJF) over ~43.1 years — trailing buy-and-hold by 5.4% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | WaveTrend (8/6/4) ✓ | Weekly | 9.8% | 0.53 | -57.3% | 91.4% | 35 | -5.4% |
| 2 | Rate of Change ✓ | Weekly | 9.7% | 0.48 | -67.4% | 49.3% | 140 | -5.6% |
| 3 | MACD ✓ | Weekly | 8.8% | 0.46 | -74.2% | 48.8% | 86 | -6.4% |
| 4 | Money Flow Index ✓ | Daily | 8.7% | 0.45 | -65.8% | 67.8% | 59 | -6.5% |
| 5 | ADX / DMI ✓ | Weekly | 7.2% | 0.44 | -48.3% | 52.7% | 55 | -8.0% |
| 6 | Holy Grail Confluence ✓ | Weekly | 6.2% | 0.45 | -50.9% | 92.9% | 14 | -9.0% |
| 7 | EMA 50/200 Cross ✓ | Daily | 8.2% | 0.42 | -54.6% | 53.6% | 28 | -7.0% |
| 8 | Holy Grail Confluence ✓ | Daily | 6.7% | 0.41 | -74.3% | 74.6% | 71 | -8.6% |
| 9 | Donchian Midline ✓ | Weekly | 7.5% | 0.41 | -63.1% | 42.6% | 129 | -7.7% |
| 10 | Donchian Breakout ✓ | Weekly | 6.9% | 0.4 | -56.3% | 59.5% | 37 | -8.3% |
| 11 | EMA 20/50 Cross ✓ | Weekly | 7.3% | 0.39 | -58.2% | 57.9% | 19 | -7.9% |
| 12 | RSI Trend (>50) ✓ | Weekly | 6.6% | 0.38 | -66.0% | 43.0% | 135 | -8.6% |
| 13 | Bollinger Mean-Reversion ✓ | Weekly | 5.8% | 0.37 | -41.9% | 76.7% | 30 | -9.4% |
| 14 | SMA 50/200 Cross ✓ | Daily | 6.5% | 0.36 | -54.5% | 52.9% | 34 | -8.8% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Raymond James Financial (RJF), WaveTrend (8/6/4) on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.